Article

A Cohort Effect on Serum Testosterone Levels in Finnish Men.

A Perheentupa, Department of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland.
European Journal of Endocrinology (Impact Factor: 3.69). 11/2012; 168(2). DOI: 10.1530/EJE-12-0288
Source: PubMed

ABSTRACT OBJECTIVE: To investigate whether a population-level decline in serum testosterone (T) exists in Finnish men. In comparison to other European populations, Finnish men have compared well in studies of reproductive health (i.e. semen quality, incidence of cryptorchidism and testicular cancer), thus we expected no significant cohort dependent decrease in serum T. METHODS: we analysed serum levels of T, gonadotrophin and sex hormone binding globulin (SHBG) in 3271 men representing different ages (25-74 y) and birth cohorts within three large Finnish population surveys conducted in 1972, 1977 and 2002. RESULTS: Serum T levels decreased (from 25.3 nmol/l in 25-29 year old men gradually to 16.9 nmol/l in 70-74 year old men), whereas SHBG and gonadotrophin levels increased with increasing age. In addition, a significant secular trend in T (total and free), SHBG and gonadotrophin levels was observed with lower levels in more recently born age-matched men. Serum T decreased in men aged 60-69 years from 21.9 nmol/l (men born 1913-1922) to 13.8 nmol/l (men born 1942-51). These decreases remained significant following adjustment for body mass index. An age-independent birth cohort effect existed on reproductive hormones measured in the Finnish men. In concert with the lower fT levels we observed lower gonadotrophin levels, suggesting that whilst there may be detrimental changes at the gonad level, the hypothalamus-pituitary -axis is not responding appropriately to this change. CONCLUSIONS: The more recently born Finnish men have lower T levels than their earlier born peers. This study offers no explanation for this substantial recent adverse development.

0 Followers
 · 
564 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although common reproductive problems, such as male infertility and testicular cancer, present in adult life, strong evidence exists that these reproductive disorders might have a fetal origin. The evidence is derived not only from large epidemiological studies that show birth-cohort effects with regard to testicular cancer, levels of testosterone and semen quality, but also from histopathological observations. Many infertile men have histological signs of testicular dysgenesis, including Sertoli-cell-only tubules, immature undifferentiated Sertoli cells, microliths and Leydig cell nodules. The most severe gonadal symptoms occur in patients with disorders of sexual development (DSDs) who have genetic mutations, in whom even sex reversal of individuals with a 46,XY DSD can occur. However, patients with severe DSDs might represent only a small proportion of DSD cases, with milder forms of testicular dysgenesis potentially induced by exposure to environmental and lifestyle factors. Interestingly, maternal smoking during pregnancy has a stronger effect on spermatogenesis than a man's own smoking. Other lifestyle factors such as alcohol consumption and obesity might also have a role. However, increasing indirect evidence exists that exposure to ubiquitous endocrine disrupting chemicals, present at measurable concentrations in individuals, might affect development of human fetal testis. If confirmed, health policies to prevent male reproductive problems should not only target adult men, but also pregnant women and their children.
    Nature Reviews Endocrinology 06/2014; 10(9). DOI:10.1038/nrendo.2014.97 · 12.96 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: AimsLow androgen levels have been linked with an increased risk of cardiovascular disease in men. Previous studies have suggested that androgens directly inhibit atherosclerotic lesion formation although the underlying mechanisms for this remain unclear. This study addressed the hypothesis that endogenous androgens inhibit arterial remodelling by a direct action on the androgen receptor (AR) in the vascular wall.Methods and resultsWe studied a series of novel mouse lines with cell-specific deletion of the AR in either the endothelium or in smooth muscle cells or both cell types. Findings were compared with a model of global androgen deficiency in wild-type mice (castrated). We characterized the cardiovascular phenotype, vascular pharmacology and histology, and assessed neointimal lesion formation following vascular injury to the femoral artery. Cell-specific AR deletion did not alter body weight, circulating testosterone levels or seminal vesicle weight, but caused limited alterations in arterial contractility and blood pressure. Neointimal lesion formation was unaltered by selective deletion of AR from the vascular endothelium, smooth muscle, or both cell types. Castration in wild-type mice increased neointimal lesion volume (Sham vs. Castration: 2.4 × 107 ± 4.5 × 106 vs. 3.9 × 107 ± 4.9 × 106 µm3, P = 0.04, n = 9–10).ConclusionVascular cell-specific AR deletion had no effect on neointimal lesion formation, while low systemic androgen levels adversely affect neointimal lesion size. These findings suggest that the cardio-protective effects of androgens are mediated either by AR outside the vasculature or by AR-independent mechanisms.
    Cardiovascular Research 06/2014; 103(2). DOI:10.1093/cvr/cvu142 · 5.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND Quantitative data on soft tissue aging of the face are scarce, particularly in men.OBJECTIVE Magnetic resonance imaging (MRI) was used to quantify and compare facial soft tissue loss in men.MATERIALS AND METHODS Two thousand thirty-seven MRIs were screened and 30 male subjects were divided into young, middle, and old-aged groups. A blinded radiologist measured temporal, infraorbital, and medial and lateral cheek areas.RESULTSThe mean thickness of the subcutaneous tissue in the temporal area was 12.5, 10.9, and 9.6 mm in the young, middle, and older age groups, respectively (p < .001). A 40% reduction in the skin thickness was seen in the infraorbital areas. Finally, a decrease of 1.5 and 2.7 mm in medial cheeks (p < .001), and 0.9 and 1.6 mm (p = .03) in lateral cheeks were measured in middle and old age groups.CONCLUSIONA steady and significant decline in the soft tissue thickness was noted at all measured sites in men over time. These findings are in contrast to our recently study in women showing dramatic loss of soft tissue between the ages of 30 and 60 with no significant differences between the middle and old-aged groups. These results have implications for volume correction and maintenance of a youthful appearance in the aging male face.
    Dermatologic Surgery 06/2014; 40(7). DOI:10.1111/DSU.0000000000000035 · 1.56 Impact Factor